Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Fuss und Sprunggelenk is Scopus-indexed (Q4, CiteScore 0.4). It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier GmbH.
Checked against the index lists dated .
ISSN 1619-9987Verify ISSN ↗1619-9995Verify ISSN ↗
Publisher: Elsevier GmbH
Cost to publish: About US$2,860 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Orthopedics and Sports Medicine | 310 / 340 | 8th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q4, CiteScore 0.4.
Fuss und Sprunggelenk is Q4 in Orthopedics and Sports Medicine (rank 310 of 340), by CiteScore 2025.
Fuss und Sprunggelenk is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.4, quartile Q4, 8th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.156, quartile Q4, with an H-index of 12.
The publisher lists an article processing charge of about US$2,860 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Fuss und Sprunggelenk is published by Elsevier GmbH. Its print ISSN is 1619-9987 and its online ISSN is 1619-9995.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Fuss und Sprunggelenk has an h-index of 26 and a 2-year mean of 0.15 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #303 of 331 Scopus journals in Orthopedics and Sports Medicine.
Fuss und Sprunggelenk published 88 papers in 2025; its busiest recent year was 2022 with 112. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 49 research articles (2025–2026), authors are most often from Germany (68%), Switzerland (10.9%) and Netherlands (3.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.